Prothionamide - Misplaced Pages

This is an old revision of this page, as edited by MahdiBot (talk | contribs) at 15:33, 20 January 2013 (r2.7.1) (Robot: Adding fa:پروتیونامید). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 15:33, 20 January 2013 by MahdiBot (talk | contribs) (r2.7.1) (Robot: Adding fa:پروتیونامید)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound

Prothionamide
Clinical data

AHFS/Drugs.com	International Drug Names
ATC code	J04AD01 (WHO)
Identifiers
IUPAC name 2-propylpyridine-4-carbothioamide
CAS Number	14222-60-7
PubChem CID	666418
UNII	76YOO33643
CompTox Dashboard (EPA)	DTXSID7045940
ECHA InfoCard	100.034.615
Chemical and physical data
Formula	C₉H₁₂N₂S
Molar mass	180.271 g/mol g·mol
(verify)

Protionamide (or prothionamide) is a drug used in the treatment of tuberculosis.

It has also been tested for use in the treatment of leprosy.

References

Wang F, Langley R, Gulten G; et al. (2007). "Mechanism of thioamide drug action against tuberculosis and leprosy". J. Exp. Med. 204 (1): 73–8. doi:10.1084/jem.20062100. PMC 2118422. PMID 17227913. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
Fajardo TT, Guinto RS, Cellona RV, Abalos RM, Dela Cruz EC, Gelber RH (2006). "A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy". Am. J. Trop. Med. Hyg. 74 (3): 457–61. PMID 16525107. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

Rifamycins/ RNA polymerase inhibitor	Rifampicin Rifabutin Rifapentine Rifalazil
Antifolates/DSI	Dapsone Acedapsone Diucifon Promin Solasulfone Sulfoxone
ASA	4-Aminosalicylic acid (Calcium aminosalicylate Sodium aminosalicylate)
Topoisomerase inhibitors/ quinolones	Gatifloxacin Moxifloxacin